Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Y-Mabs Therapeutics Inc
(NQ:
YMAB
)
13.82
-0.17 (-1.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Y-Mabs Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
INVESTOR NOTICE: Y-mAbs Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Y-mAbs Class Action Lawsuit - YMAB
January 19, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YMAB
January 19, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Y-mAbs Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
January 19, 2023
From
The Schall Law Firm
Via
Business Wire
Analyst Ratings for Y-mAbs Therapeutics
December 02, 2022
Via
Benzinga
Analysts Slash Y-mAbs Therapeutics Price Targets As Uncertainty Looms Over Neuroblastoma Hopeful
October 31, 2022
Via
Benzinga
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Y-mAbs Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
January 18, 2023
From
The Schall Law Firm
Via
Business Wire
Y-mAbs Therapeutics Plans To Deprioritize Omburtamab For Pediatric Cancer, Cuts One Third Of Workforce
January 05, 2023
Via
Benzinga
NASDAQ:YMAB Investor Alert: Investigation over Possible Securities Laws Violations by Y-mAbs Therapeutics, Inc
November 18, 2022
San Diego, CA -- (SBWIRE) -- 11/18/2022 -- Y-mAbs Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Lost Money in Y-mAbs Therapeutics, Inc.?
November 16, 2022
From
Gibbs Law Group
Via
Business Wire
Where Y-mAbs Therapeutics Stands With Analysts
October 31, 2022
Within the last quarter, Y-mAbs Therapeutics (NASDAQ:YMAB) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Lost Money in Y-mABs Therapeutics, Inc.?
November 15, 2022
From
Gibbs Law Group
Via
Business Wire
Looking Into Y-mAbs Therapeutics's Recent Short Interest
November 10, 2022
Y-mAbs Therapeutics's (NASDAQ:YMAB) short percent of float has fallen 16.88% since its last report. The company recently reported that it has 3.08 million shares sold short, which is 8.47% of all...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
Gainers
Via
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 01, 2022
On Tuesday, 85 stocks hit new 52-week lows.
Via
Benzinga
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Lost Money in Y-mAbs Therapeutics, Inc.?
October 31, 2022
From
Gibbs Law Group
Via
Business Wire
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – YMAB
October 31, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
S&P 500 Down 0.5%; Crude Oil Falls Sharply
October 31, 2022
U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping around 0.5% on Monday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
During Monday's session, 96 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 31, 2022
Gainers
Via
Benzinga
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
October 31, 2022
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its...
Via
Benzinga
Nasdaq Down Over 100 Points; Chicago PMI Drops Further
October 31, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
US Stocks Start Week On Lower Note; Dow Dips Over 200 Points
October 31, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Monday.
Via
Benzinga
Grainger To Surge Over 11%? Plus This Analyst Predicts $230 For Caterpillar
October 31, 2022
UBS raised the price target on Caterpillar Inc. (NYSE: CAT) from $225 to $230. Caterpillar shares fell 1.1% to $216.85 in pre-market trading.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.